Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

NCT02018367 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDIV

Sponsor class

Conditions

Barrett's Esophagus

Interventions

DRUG: Proflavine, high resolution imaging

Sponsor

Anandasabapathy, Sharmila, M.D.

Collaborators

[object Object]
[object Object]